The monoclonal antibodies therapy treatment, which was used for treating COVID infection in former US President Donald Trump, is now available at two hospitals in Lucknow. This therapy is generally given to patients with comorbidities, where the possibility of infection taking a severe turn is quite high. Post administration of this therapy through an intravenous method, the patient is kept under observation for an hour before being discharged.
To be administered within 10 days of infection
Now available at Lucknow’s Medanta Hospital and Apollomedics Super Speciality Hospital, the monoclonal antibodies treatment therapy uses antibodies with laboratory-made proteins that mimic the immune system’s ability to fight harmful pathogens. Effective against mild or moderate COVID cases where oxygen supply is not required, this treatment is marked at ₹60,000.
Further, this therapy has to be administered within 10 days of testing positive for the infection, to block the entry of the novel coronavirus in human cells, thereby, preventing its replication and consequent damages.
Reportedly, on Sunday, a 55-year-old male COVID patient admitted to Medanta Hospital, became the first recipient of this ‘cocktail therapy’ in Lucknow. Post-administration of the drug through an intravenous method, which takes around 60 minutes, the patient witnessed a significant amount of reduction in the symptoms and the viral load.
Recently approved by India’s Central Drugs Standards Control Organisation (CDSCO), this ‘cocktail therapy’ was used in the COVID treatment of the 45th US President, Donald Trump. Famously referred to as the ‘Trump Cocktail’, it is administered through a drug- Regeneron, a combination of two artificial antibodies developed in labs- Castrivimab and Imdevimab.
–With inputs from IANS
